Your browser doesn't support javascript.
loading
Elevated Urinary Rab10 Phosphorylation in Idiopathic Parkinson Disease.
Wang, Shijie; Unnithan, Shakthi; Bryant, Nicole; Chang, Allison; Rosenthal, Liana S; Pantelyat, Alexander; Dawson, Ted M; Al-Khalidi, Hussein R; West, Andrew B.
Afiliação
  • Wang S; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina, USA.
  • Unnithan S; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
  • Bryant N; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina, USA.
  • Chang A; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina, USA.
  • Rosenthal LS; Department of Neurology, The Johns Hopkins University, Baltimore, Maryland, USA.
  • Pantelyat A; Department of Neurology, The Johns Hopkins University, Baltimore, Maryland, USA.
  • Dawson TM; Department of Neurology, The Johns Hopkins University, Baltimore, Maryland, USA.
  • Al-Khalidi HR; Neurodegeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • West AB; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Mov Disord ; 37(7): 1454-1464, 2022 07.
Article em En | MEDLINE | ID: mdl-35521944

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Proteínas rab de Ligação ao GTP / Serina-Treonina Proteína Quinase-2 com Repetições Ricas em Leucina Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Proteínas rab de Ligação ao GTP / Serina-Treonina Proteína Quinase-2 com Repetições Ricas em Leucina Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article